Protective effects of emodin on intestinal mucosal barrier in acute radiation enteritis

Yu WANG,Dong-zhi ZHOU,Xin-xin XIA,Ping-ping HAN,Li-jun CAO

DOI: https://doi.org/10.3969/j.issn.1671-8259.2013.02.026

2013-01-01

Abstract:Objective: To investigate the effects and mechanisms of emodin on acute radiation enteritis models and intestinal mucosal barrier. Methods: Totally 50 healthy male SD rats were randomly divided into normal group, model group, emodin prevention group, emodin treatment group and SiMiDa group. Emodin prevention group had been given emodin for 3 consecutive days in advance. Except normal group, the others were given a single dose of 10 Gy 6 MV of higher-energy X-rays on the abdominal region to establish acute radiation enteritis models. After 6 h, emodin prevention group, emodin treatment group and SiMiDa group were given intragastric administration for 4 days. The morphologic indexes were measured by light microscopy and the image analysis system. Intestinal diamine oxidase (DAO) activities as well as bacteria translocation rates of liver, spleen and mesenteric lymph node were measured. Intestinal tumor necrosis factor alpha (TNF-α) was measured by ELISA and nitric oxide (NO) level was measured by spectrophotometer. Results: Emodin prevention group, emodin treatment group and SiMiDa group had significantly higher levels of villus height, crypt depth, thickness of mucosa and entire wall as well as DAO activities than model group (P<0.05). Emodin prevention group, emodin treatment group and SiMiDa group had significantly decreased bacteria translocation rates of liver, spleen and mesenteric lymph node as well as TNF-a activities and NO levels (P<0.05). There were no differences between emodin prevention group and emodin treatment group (P≤0.05). Conclusion: Emodin could significantly increase villus height of the small intestine, crypt depth and mucosal layer thickness, enhance intestinal tissue DAO activities, protect the intestinal mucosa, reduce bacterial translocation rate, and reduce TNF-a expression in the intestinal tissue and NO generation. There are no significant differences between prophylaxis and treatment administration of emodin.